Maximum quantity allowed is 999
请选择数量
CAS RN: 180200-66-2 | 产品编码: G0627
Gatifloxacin Sesquihydrate

产品编码 | G0627 |
纯度/分析方法 | >95.0%(T)(HPLC) |
分子式/分子量 | C__1__9H__2__2FN__3O__4·1^^1/__2H__2O = 402.42 |
外观与形状(20°C) | 固体 |
储存温度 | 冷藏 (0-10°C) |
储存在惰性气体下 | 存放于惰性气体之中 |
应避免的情况 | 空气,湿气 (吸湿),加热 |
CAS RN | 180200-66-2 |
Reaxys-RN | 14390028 |
MDL编号 | MFCD22373645 |
技术规格
Appearance | White to Light yellow powder to crystal |
Purity(HPLC) | min. 95.0 area% |
Purity(Neutralization titration) | min. 95.0 % |
Melting point | 179.0 to 183.0 °C |
NMR | confirm to structure |
物性(参考值)
熔点 | 181 °C |
GHS
相关法规
RTECS# | VB1983650 |
运输信息
HS编码* | 2933.59-000 |
应用
Gatifloxacin: An 8-Methoxy Fluoroquinolone Antibacterial Agent with a Broad Antibacterial Spectrum
Gatifloxacin (AM-1155) is an 8-methoxy fluoroquinolone antibacterial agent with a 3-methylpiperazinyl substituent at C7. Fluoroquinolone fungicidal antibacterial agents are inhibitors of bacterial DNA gyrase and topoisomerase IV.1,2) DNA gyrase is an essential enzyme involved in the replication, transcription and repair of bacterial DNA. Topoisomerase IV is an enzyme known to play a key role in the division of chromosomal DNA during bacterial cell division. As just described, the mechanism of action of fluoroquinolones is different from that of other antibiotics. Therefore, there is no cross-resistance between fluoroquinolones and the other classes of antibiotics. In particular, gatifloxacin has a broader spectrum of antibacterial activity than the older fluoroquinolones and shows good activity against many Gram-positive and Gram-negative bacteria, atypical organisms and some anaerobes.3) In addition, gatifloxacin has higher selectivity for bacterial type II topoisomerases.4) (The product is for research purpose only.)
References
- 1) In vitro and in vivo antibacterial activities of AM-1155, a new 6-fluoro-8-methoxy quinoline
- 2) Quinolone-mediated bacterial death (a review)
- 3) Comparison of the antibacterial activities of the quinolones Bay 12-8039, gatifloxacin (AM 1155), trovafloxacin, clinafloxacin, levofloxacin and ciprofloxacin
- 4) Inhibitory Activities of Gatifloxacin (AM-1155), a Newly Developed Fluoroquinolone, against Bacterial and Mammalian Type II Topoisomerases
- 5) Separation of levofloxacin, ciprofloxacin, gatifloxacin, moxifloxacin, trovafloxacin and cinoxacin by high-performance liquid chromatography: application to levofloxacin determination in human plasma
- 6) Gatifloxacin (a review)
产品文档 (部分产品的分析图谱无法提供,敬请谅解。)
化学品安全说明书(SDS)
请选择语言。
如需更多帮助,请联系我 们。
技术规格
CoA及其他文档
请输入批号
批号输入有误。请输入中横线前的4-5个字母数字字符。
示例 CoA
可下载CoA示例。注:该示例不一定是最新批次的CoA。
目前没有该产品的 CoA 示例。
分析图谱
请输入批号
批号输入有误。请输入中横线前的4-5个字母数字字符。
很抱歉,您搜索的分析图谱无法提供。